HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Capital Expenditures (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Capital Expenditures came in at -$2.9 million in Q2 2021, down 44.95% year-over-year from -$5.2 million in Q2 2020, and up 52.83% quarter-over-quarter from -$6.1 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Capital Expenditures (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Capital Expenditures for 4 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Capital Expenditures fell 44.95% year-over-year to -$2.9 million in Q2 2021; TTM through Jun 2021 was -$13.0 million, a 47.83% decrease from a year earlier, with the FY2025 full-year figure at -$14.1 million, up 21.11% from the prior year.
  • Capital Expenditures was -$2.9 million for Q2 2021 at HUTCHMED (China), up from -$6.1 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $9.8 million in Q4 2018 and troughed at -$6.1 million in Q1 2021.
  • A 4-year average of -$1.3 million and a median of -$1.9 million in 2019 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures plunged 226.81% in 2019 and rose 20.75% in 2020, its largest moves.
  • Over 4 years, Capital Expenditures stood at $9.8 million in 2018, then sank by 130.12% to -$3.0 million in 2019, then surged by 33.21% to -$2.0 million in 2020, then sank by 44.95% to -$2.9 million in 2021.
  • The last three Capital Expenditures figures came in at -$2.9 million (Q2 2021), -$6.1 million (Q1 2021), and -$2.0 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn -
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn 34.68 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn 40.90 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -1.87 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -2.86 Mn
Mar 31, 2021 -6.06 Mn
Jun 30, 2020 -1.97 Mn
Mar 31, 2020 -2.09 Mn
Dec 31, 2019 -2.95 Mn
Sep 30, 2019 -1.77 Mn
Jun 30, 2019 -2.49 Mn
Mar 31, 2019 -1.36 Mn
Dec 31, 2018 9.80 Mn
Sep 30, 2018 -1.35 Mn
Jun 30, 2018 -761,000.00
Mar 31, 2018 -1.32 Mn